◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

IOVANCE BIOTHERAPEUTICS, INC.

CIK: 1425205 SIC: 2836
$263.50M
Revenue
$-390.98M
Net Income
28.66%
Gross Margin
-153.08%
Op. Margin
$-630.96M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 15 of 15 annual reports available (2011 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2015
(Dec 31, 2015)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
+ Total Revenue $263.50M $263.50M $164.07M $1.19M - - - - - - - - - - - -
Revenue Growth % 0.0% 60.6% 13699.0% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Cost of Revenue $187.99M $173.18M $93.25M $1.03M - - - - - - - - - - - -
+ Gross Profit $75.51M $90.32M $70.82M $156.00K - - - - - - - - - - - -
Gross Margin % 28.7% 34.3% 43.2% 13.1% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Operating Expenses $666.86M $666.86M $559.35M $461.75M $398.88M $342.70M $261.94M $206.87M $128.26M $92.88M $53.64M $27.86M $12.04M $22.64M $8.13M $21.22M
Research & Development $302.62M $300.27M $276.23M $333.19M $294.78M $259.04M $201.73M $166.02M $99.83M $71.61M $28.04M $15.47M $2.70M $1.33M $1.66M $1.76M
+ Operating Income $-403.36M $-403.36M $-395.28M $-460.56M $-398.88M $-342.70M $-261.94M $-206.87M $-128.26M $-92.88M $-53.64M $-27.86M $-12.04M $-22.64M $-8.13M $-21.22M
Operating Margin % -153.1% -153.1% -240.9% -38735.0% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Interest Expense - - - - - - - - - - - - $-5.66K $444.73K $1.92M $151.51K
Interest Income $10.31M $10.31M $20.27M $13.04M $2.98M $451.00K $2.36M $9.32M $4.68M $813.00K $745.00K $200.00K $6.00K - - -
Other Income/Expense - - - - - - - - - - - $200.00K $5.66K $-2.74M $4.82M $-4.48M
Income Before Tax $-393.05M $-393.05M $-375.00M $-447.52M $-395.89M $-342.25M - - - - - - - - - -
Income Tax Expense $-2.07M $-2.07M $-2.83M $-3.48M - - - - - - - - - - - -
+ Net Income $-390.98M $-390.98M $-372.18M $-444.04M $-395.89M $-342.25M $-259.58M $-197.56M $-123.58M $-92.06M $-52.89M $-27.66M $-12.03M $-25.38M $-3.31M $-25.69M
Net Margin % -148.4% -148.4% -226.8% -37345.4% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Basic EPS -1.09 -1.09 -1.28 -1.89 -2.49 -2.23 -1.88 -1.59 nan nan nan nan nan nan nan nan
Diluted EPS nan -1.09 -1.28 -1.89 -2.49 -2.23 -1.88 -1.59 nan nan nan nan nan nan nan nan
Basic Shares Outstanding - 357K 290K 235K 159K 153K 138K 124K - - - - - - - -
Diluted Shares Outstanding - 357K 290K 235K 159K 153K 138K 124K - - - - - - - -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2015
(Dec 31, 2015)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
Cash & Cash Equivalents $163.08M $115.69M $114.89M $231.73M $78.23M $67.33M $13.97M $82.15M $145.37M $106.72M $13.64M $44.91M $19.67M - $510.22K
Short-term Investments $133.90M $208.09M $164.98M $240.11M $426.18M $562.11M $293.11M $386.37M - - - - - - -
Accounts Receivable $82.45M $69.34M $151.00K - - - - - - - - - - - -
Inventory $51.68M $51.52M $10.37M - - - - - - - - - - - -
Other Current Assets $11.58M $12.38M $17.46M $7.27M $3.55M $6.66M $9.41M $6.85M $3.92M $3.04M $277.00K $66.13K $173.72K $5.00K $9.39K
Total Current Assets $442.69M $457.02M $307.85M $479.12M $507.96M $636.10M $316.49M $475.37M $149.29M $169.51M $103.98M $44.98M $19.85M $7.28K $524.08K
Property Plant & Equipment $131.11M $109.08M $114.03M $105.23M $100.94M $59.16M $8.54M $2.68M $2.45M $2.37M $1.68M $1.53M $27.76K $22.14K $28.35K
Intangible Assets $279.32M $282.40M $229.26M - - - - - - - - - - - -
Long-term Investments - - - - $91.59M - - - - - - - - - -
Other Non-current Assets $8.17M $369.00K $270.00K $189.00K $1.78M $12.92M $3.48M $2.76M $3.63M - - - - - -
Total Assets $913.17M $910.43M $780.35M $663.98M $777.33M $768.46M $344.65M $480.82M $155.37M $171.89M $105.65M $46.51M $19.87M $29.41K $568.43K
Accounts Payable $22.16M $27.51M $33.12M $26.60M $27.38M $13.51M $15.57M $2.74M $1.23M $863.00K $958.00K $1.25M $412.98K $1.10M $190.05K
Accrued Liabilities $111.16M $81.94M $69.41M $52.30M $56.77M $35.07M $16.27M $11.66M $8.66M $4.11M $586.00K $327.85K $1.52M - -
Total Current Liabilities $138.36M $122.34M $110.31M $91.48M $89.20M $54.87M $39.08M $14.40M $9.89M $4.97M $1.63M $1.66M $2.27M $11.35M $13.35M
Deferred Tax Liabilities $31.83M $32.31M $17.35M - - - - - - - - - - - -
Other Non-current Liabilities - - - - - $11.71M $2.35M $230.00K - - - - - - -
Total Liabilities $214.59M $200.02M $195.74M $164.34M $155.67M $111.96M $45.68M $14.63M $9.89M - - - - - -
Common Stock $17.00K $13.00K $11.00K $8.00K $7.00K $6.00K $5.00K $5.00K $3.00K $3.00K $2.00K $1.41K $835.00 $3.41K $3.25K
Retained Earnings $-2.78B $-2.38B $-2.01B $-1.57B $-1.17B $-830.19M $-570.61M $-372.76M $-249.18M $-157.12M $-104.22M $-76.56M $-64.53M $-30.68M $-27.38M
Total Stockholders Equity $698.58M $710.40M $584.61M $499.64M $621.66M $656.50M $298.97M $466.19M $145.48M $166.92M $104.02M $44.85M $17.60M $-11.32M $-12.78M
Total Liabilities & Equity $913.17M $910.43M $780.35M $663.98M $777.33M $768.46M $344.65M $480.82M $155.37M $171.89M $105.65M $46.51M $19.87M $29.41K $568.43K
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2015
(Dec 31, 2015)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
Net Income $-507.14M $-390.98M $-372.18M $-444.04M $-395.89M $-342.25M $-259.58M $-197.56M $-123.58M $-92.06M $-52.89M $-27.66M $-12.03M $-25.38M $-3.31M $-25.69M
Depreciation & Amortization $19.05M $12.86M $11.26M $11.57M $9.31M $3.11M $1.14M $1.17M $956.00K $952.00K $978.00K $999.00K $88.22K $7.09K $6.21K $2.70K
Stock-based Compensation $84.49M $61.58M $109.63M $62.62M $84.02M $69.77M $40.89M $24.28M $20.03M $11.97M $18.90M $8.52M $3.81M $2.75M $4.20M $14.61M
Deferred Income Tax $-3.76M $-2.07M $-2.83M $-3.48M - - - - - - - - - - - -
Change in Receivables $5.30M $13.11M $69.19M $149.00K - - - - - - - - - - - -
Change in Inventory $35.21M $14.21M $44.38M $10.12M - - - - - - - - - - - -
Change in Payables $-1.66M $-6.66M $-7.84M $4.83M $5.88M $6.98M $-2.96M $12.71M $1.51M $369.00K $-250.00K $-290.00K - - $908.22K $159.76K
Operating Cash Flow $-577.24M $-302.41M $-352.98M $-361.82M $-292.76M $-227.94M $-205.13M $-158.89M $-101.25M $-78.71M $-32.67M $-18.38M - $-3.66M $-2.24M $-6.19M
Capital Expenditure $53.72M $33.84M $11.07M $22.29M $20.43M $37.57M $46.79M $6.92M $1.20M $1.03M $1.52M $1.14M $1.59M $12.71K - $31.05K
Acquisitions - - - $212.63M - - - - - - - - - - - -
Investing Cash Flow $93.07M $47.50M $-96.41M $-155.24M $256.45M $132.00K $-317.85M $90.03M $-386.28M $58.68M $8.89M $-71.21M - $-12.71K - $-81.05K
Stock Issued $617.26M $306.31M $397.30M $463.28M $189.50M $203.16M $567.04M - $398.82M $53.66M $95.69M $68.31M $32.24M $7.13M $250.00K $873.00K
Financing Cash Flow $600.63M $300.77M $390.66M $462.96M $190.15M $239.27M $576.42M $6.13M $424.31M $58.69M $96.90M $78.27M - $23.35M $1.73M $5.49M
Net Change in Cash $119.36M $47.01M $-59.27M $-56.84M $153.85M $11.46M - - $-63.22M $38.66M $73.13M $-31.27M $25.24M $19.67M $-510.22K $-782.25K
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $67.45M $58.55M $176.73M $90.38M
Cost of Revenue $38.48M $31.52M $130.07M $55.46M
Operating Expenses $162.36M $147.62M $506.63M $399.08M
Research & Development $75.17M $67.04M $229.07M $205.22M
Operating Income $-94.90M $-89.07M $-329.90M $-308.70M
Interest Income $1.24M $4.00M $8.57M $10.70M
Income Before Tax $-93.66M $-85.06M $-321.33M $-298.00M
Income Tax Expense $-2.40M $-1.52M $-2.25M $-4.39M
Net Income $-91.25M $-83.54M $-319.07M $-293.62M
Basic EPS -0.25 -0.28 -0.94 -1.03
Basic Shares Outstanding $364.04K $303.27K $340.62K $284.84K
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $158.13M $115.69M
Short-term Investments $142.67M $208.09M
Accounts Receivable $66.76M $69.34M
Inventory $51.71M $51.52M
Other Current Assets $9.82M $12.38M
Total Current Assets $429.09M $457.02M
Property Plant & Equipment $126.65M $109.08M
Intangible Assets $285.21M $282.40M
Other Non-current Assets $9.27M $369.00K
Total Assets $904.95M $910.43M
Accounts Payable $31.24M $27.51M
Total Current Liabilities $125.78M $122.34M
Deferred Tax Liabilities $31.66M $32.31M
Total Liabilities $202.66M $200.02M
Common Stock $16.00K $13.00K
Retained Earnings $-2.70B $-2.38B
Total Stockholders Equity $702.29M $710.40M
Total Liabilities & Equity $904.95M $910.43M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-91.25M $-83.54M $-319.07M $-293.62M
Depreciation & Amortization $9.01M $9.73M $9.14M $7.98M
Stock-based Compensation $11.90M $31.01M $49.76M $78.65M
Deferred Income Tax - - $-2.25M $-4.39M
Change in Receivables - - $-2.58M $55.62M
Change in Inventory - - $10.21M $25.45M
Change in Payables - - $-1.45M $-1.77M
Operating Cash Flow - - $-249.84M $-279.68M
Capital Expenditure - - $24.52M $6.90M
Investing Cash Flow - - $46.72M $-120.09M
Stock Issued - - $250.53M $397.30M
Financing Cash Flow - - $244.60M $388.36M
Net Change in Cash - - $42.05M $-10.78M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...